European Journal of Cancer Supplements, 1359-6349

Tidskrift

Fler filtreringsmöjligheter
  1. Adjuvant radiotherapy after radical prostatectomy

    Dirk Bottke, Per-Anders Abrahamsson, Birgitta Welte & Thomas Wiegel, 2007, I: European Journal of Cancer Supplements. 5, 5, s. 171-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Anti proliferative activity on human colon cancer cells treated in vitro with extracts from Bolivian foods and other plants

    G. Rodrigo, G. Almanza, Rui-Dong Duan & Björn Åkesson, 2008, I: EJC Supplements. 6, 9, s. 198-198

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

    S Margolin, L Carlsson, M Hellström, P Karlsson, E Lidbrink, B Linderholm, H Lindman, Per Malmström, D Sköld Pettersson & J Bergh, 2008, I: European Journal of Cancer Supplements. 6, 7, s. 116-117

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis

    Carina Forsare, Anette AhlinGullers, M. L. Fjallskog, P. Malmstrom & Mårten Fernö, 2010, I: EJC Supplements. 8, 3, s. 95-96

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  5. E28. Breast tolerance, tibolone compared to other hormonal treatments

    Hakan L. Olsson, 2004 dec, I: European Journal of Cancer, Supplement. 2, 9 SPEC. ISS., s. 79-80 2 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Early breast cancer detection: validation of a commercially available blood-based gene expression test

    D. Tobin, N. Hagen, A. L. Borresen-Dale, A. Hollingsworth, E. Schlicting, P. Skaane, F. Warnberg, L. Bergkvist, Christian Ingvar & P. E. Jonsson, 2010, I: EJC Supplements. 8, 3, s. 110-110

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  7. Epigenetic target genes in malignant peripheral nerve sheath tumours identified as surrogate prognostic biomarkers

    S. Aske Danielsen, G. E. Lind, K. Sundby Hall, S. Smeland, E. van den Berg, Fredrik Mertens, M. Kolberg & R. A. Lothe, 2010, I: EJC Supplements. 8, 5, s. 163

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  8. Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5

    C. E. Ford, J. Tuomela, E. L. Hedditch, Lena Axelsson, Qing Liu, R. L. Ward, P. Harkonen & Tommy Andersson, 2010, I: EJC Supplements. 8, 5, s. 43

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project

    J. Coebergh, C. J. G. van den Hurk, H. H. Storm, R. Zanetti, H. Comber, A. Antilla, Joakim Dillner, F. Bray, S. Siesling & E. Steliarova-Foucher, 2009, I: EJC Supplements. 7, 2, s. 201-202

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Föregående 1 2 3 Nästa